Esperion Therapeutics Inc (NAS:ESPR)
$ 2.12 0.12 (6%) Market Cap: 416.00 Mil Enterprise Value: 472.28 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 53/100

Esperion Therapeutics Inc Annual Shareholders Meeting Transcript

May 29, 2019 / 12:00PM GMT
Release Date Price: $50.33 (-2.99%)
Keith F. Lenden
Esperion Therapeutics, Inc. - VP of Corporate Development & Strategy

Good morning, and welcome to the 2019 Esperion Annual Meeting of Stockholders. I would now like to turn the meeting over to Tim Mayleben, President and Chief Executive Officer of Esperion. Mr. Mayleben, please go ahead.

Timothy M. Mayleben
Esperion Therapeutics, Inc. - President, CEO & Director

Thank you, Keith, and good morning, everyone. I'd like to welcome you to the Sixth Annual Esperion Stockholders Meeting, which is now called to order. We are excited to be hosting of our fourth annual virtual meeting of stockholders. We have stockholders attending through the web portal that we have provided. And following the meeting, we will answer any questions that you may have.

I'll be acting as Chairman and Inspector of Elections of this meeting. Rick Bartram, our Chief Financial Officer, will act as Secretary for the meeting.

As noted in the notice of annual meeting and the proxy statement previously made available to stockholders via the Internet,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot